Skip to main content
Premium Trial:

Request an Annual Quote

Michael Brawer

MDxHealth has appointed Michael Brawer as chief medical officer. Brawer is a urologist and former professor of urology and pathology. He most recently served as vice president of medical affairs for urology at Myriad Genetics, where he led all clinical aspects of development, education, and commercialization of the firm's prognostic prostate cancer assay. Previously, Brawer held senior leadership positions at GTx, Tokai Pharmaceuticals, and Threshold Pharmaceuticals. HE was also a practicing urologist and the director of the Northwest Prostate Institute for almost a decade, and held teaching positions in pathology and urology at the University of Washington and University of Arizona.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.